Hikma Pharmaceuticals (OTCMKTS:HKMPY) Stock Price Down 2.6% – What’s Next?
by Michael Walen · The Markets DailyHikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report)’s stock price was down 2.6% during trading on Tuesday . The company traded as low as $41.33 and last traded at $41.33. Approximately 1,515 shares changed hands during mid-day trading, a decline of 38% from the average daily volume of 2,431 shares. The stock had previously closed at $42.45.
Hikma Pharmaceuticals Stock Performance
The firm has a 50 day moving average of $41.66 and a two-hundred day moving average of $46.30.
About Hikma Pharmaceuticals
Hikma Pharmaceuticals is a multinational pharmaceutical company founded in Amman, Jordan, in 1978. Headquartered in London, the company develops, manufactures and markets a broad range of branded and non-branded generic medicines, as well as speciality injectable products. Over four decades, Hikma has grown from a regional pharmaceutical supplier to a global healthcare provider, maintaining a focus on quality manufacturing and regulatory compliance.
The company operates across three core business segments: branded generics, speciality injectables and non-branded generics.